Skip to main content

ADVERTISEMENT

Mary Mihalovic

12/17/2012
Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.
Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.
Patients with active ulcerative...
12/17/2012
First Report Managed Care
News Connection
01/24/2012
After 15 months of therapy with etanercept, a tumor necrosis factor alpha antagonist, patients with juvenile idiopathic arthritis (JIA) who had had low baseline disability scores, prior disease-modifying antirheumatic drug (DMARD) use, and...
After 15 months of therapy with etanercept, a tumor necrosis factor alpha antagonist, patients with juvenile idiopathic arthritis (JIA) who had had low baseline disability scores, prior disease-modifying antirheumatic drug (DMARD) use, and...
After 15 months of therapy with...
01/24/2012
First Report Managed Care
12/15/2014
A 40% increase in requests for prehospital emergency medical services was observed over a 10-year period, according to a recent study.
A 40% increase in requests for prehospital emergency medical services was observed over a 10-year period, according to a recent study.
A 40% increase in requests for...
12/15/2014
First Report Managed Care
04/23/2012
A woman’s risk of dying as a direct result of breast cancer increases with age, according to results of a recent study of postmenopausal women with hormone receptor positive disease [JAMA. 2012;307(6):590-597]. This risk increased regardless...
A woman’s risk of dying as a direct result of breast cancer increases with age, according to results of a recent study of postmenopausal women with hormone receptor positive disease [JAMA. 2012;307(6):590-597]. This risk increased regardless...
A woman’s risk of dying as a...
04/23/2012
First Report Managed Care
03/18/2014
Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.
Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.
Dolutegravir, used with abacavir...
03/18/2014
First Report Managed Care
Conference Insider
09/24/2015
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical...
09/24/2015
First Report Managed Care
11/27/2012
Cincinnati—A large percentage of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) are being prescribed maintenance therapy with inhaled corticosteroids (ICS), a practice that is not consistent with the Global...
Cincinnati—A large percentage of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) are being prescribed maintenance therapy with inhaled corticosteroids (ICS), a practice that is not consistent with the Global...
Cincinnati—A large percentage of...
11/27/2012
First Report Managed Care
News Connection
03/16/2012
The use of cangrelor, an intravenous antagonist of the P2Y12 receptor, to bridge patients after they discontinue antiplatelet therapy in preparation for coronary artery bypass graft (CABG) surgery, was shown to effectively provide platelet...
The use of cangrelor, an intravenous antagonist of the P2Y12 receptor, to bridge patients after they discontinue antiplatelet therapy in preparation for coronary artery bypass graft (CABG) surgery, was shown to effectively provide platelet...
The use of cangrelor, an...
03/16/2012
First Report Managed Care
12/15/2014
The results of a recent study found that in-hospital worsening heart failure was common and associated with higher rates of mortality, all-cause readmission, and Medicare payments.
The results of a recent study found that in-hospital worsening heart failure was common and associated with higher rates of mortality, all-cause readmission, and Medicare payments.
The results of a recent study...
12/15/2014
First Report Managed Care
02/21/2012
The use of aspirin for primary prevention of cardiovascular events was not shown to be beneficial for preventing fatal myocardial infarction (MI), stroke, or death related to cardiovascular disease (CVD) or cancer, according to results of a...
The use of aspirin for primary prevention of cardiovascular events was not shown to be beneficial for preventing fatal myocardial infarction (MI), stroke, or death related to cardiovascular disease (CVD) or cancer, according to results of a...
The use of aspirin for primary...
02/21/2012
First Report Managed Care